Lipocalin 2 over-expression facilitates progress of castration-resistant prostate cancer via improving androgen receptor transcriptional activity
Open Access
- 1 September 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (39) , 64309-64317
Abstract
Lipocalin 2 over-expression facilitates progress of castration-resistant prostate cancer via improving androgen receptor transcriptional activityKeywords
This publication has 29 references indexed in Scilit:
- Prognostic factors influencing prostate cancer‐specific survival in non‐castrate patients with metastatic prostate cancerThe Prostate, 2014
- Distinct Patterns of Dysregulated Expression of Enzymes Involved in Androgen Synthesis and Metabolism in Metastatic Prostate Cancer TumorsCancer Research, 2012
- Castration resistant prostate cancer is associated with increased blood vessel stabilization and elevated levels of VEGF and Ang‐2The Prostate, 2011
- Expanding Treatment Options for Metastatic Prostate CancerNew England Journal of Medicine, 2011
- Upregulation of MAPK pathway is associated with survival in castrate-resistant prostate cancerBritish Journal of Cancer, 2011
- EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised DiseaseEuropean Urology, 2011
- Evidence of Limited Contributions for Intratumoral Steroidogenesis in Prostate CancerCancer Research, 2010
- Androgen Levels Increase by Intratumoral De novo Steroidogenesis during Progression of Castration-Resistant Prostate CancerCancer Research, 2008
- Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor GrowthCancer Research, 2008
- Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate CancerCancer Research, 2006